RNA Clinical Trials Resources
-
Pros And Cons Of Basing Clinical Trials In Today's European Landscape
1/31/2024
Explore the essential considerations for sponsors and CROs as they navigate the advantages and challenges of clinical trial locations, particularly in the United States and Europe.
-
An Exploration Of ICIs In Cancer Therapy
1/31/2024
This collection of frequently asked questions highlights the remarkable efficacy of immune checkpoint inhibitors (ICIs) and the projected growth of the global ICI market.
-
Uncovering Hidden CRO Contract Costs Before Signing A Contract
1/22/2024
Navigating the complex landscape of clinical trials can be challenging. Utilize this reliable CRO Checklist to empower teams to stay ahead and safeguard every trial's budget effectively.
-
The Future Of mRNA For Cancer Treatment
1/9/2024
As additional mRNA-based cancer immunotherapies vaccines enter clinical development, operational and supply chain challenges must be addressed to reduce turnaround times and COGS.
-
Advancing From Single Country Phase 1 Success To Multinational Phase 1/2 Trial
1/3/2024
Explore how this partnership aims to contribute to the success of the trial by leveraging global resources and streamlining processes for efficient and timely results.
-
Accelerated Development: Gene Therapy Vs. Small Molecule
12/26/2023
Combined with the inherent difficulty of the chemistry behind gene therapy development, its pace, structure, and funding dynamics are unique among treatment modalities.
-
Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023)
11/27/2023
Dive into the forefront of immune checkpoint inhibitors clinical trials with an exploration of the latest trends and key findings.
-
Hemophilia - Global Clinical Trial Landscape
11/7/2023
Delve into the clinical landscape of hemophilia, a rare X-linked congenital bleeding disorder, across three key regions of the globe, namely Asia Pacific, Europe, and North America.
-
CRISPR Clinical Trials And Regulatory Approval Of CRISPR Therapy Drugs
10/23/2023
Navigate the intricate regulatory landscape with knowledge that can help you move your CRISPR therapies quickly and efficiently through clinical trials.
-
Transitioning From Using RUO To cGMP Chemicals For Clinical Trials
10/17/2023
Learn about the common challenges and risks associated with accelerating your molecule's timeline from lab to clinic, along with important supply chain considerations for emerging biopharma companies.